- Apple: Canaccord Genuity raises its target price from $165 to $175.
- Arvinas : Wedbush lifts PT to $113 From $94 , maintains Outperform rating
- Aviva: Company gets its only negative rating as Exane downgrades to underperfom from neutral
- Biogen : Wedbush raises price target to $314 from $312, maintains neutral rating
- The British Land Company: Goodbody cut the recommendation to hold from buy. PT at 525 pence
- Centrica: Exane BNP Paribas upgrades to neutral from underperform. PT up 0.8% to 49 pence
- Comerica Incorporated : Goldman Sachs adjusts price target to $76 from $77, maintains sell rating
- Domino's Pizza: J.P. Morgan cuts to neutral from overweight. PT 1.6% down to $530
- Lithia Motors : Goldman Sachs adjusts price target to $416 from $412, maintains neutral rating
- Monster Beverage: Citi upgrades to buy with $110 target.
- M&T Bank : Evercore ISI adjusts price target to $151 from $154, keeps in line rating
- NASDAQ 100 : Goldman Sachs raises PT on Nasdaq to $177 from $172, maintains Neutral rating
- Tesla: Credit Suisse is neutral and targets USD 800.
- Texas Capital Bancshares : Truist adjusts PT to $77 from $85, maintains Buy tating
- The Hershey Company: Deutsche Bank lifted price target to $173 from $166
- Unilever: RBC is short and has lowered its target from GBp 3700 to GBp 3600.
- Vodafone: Goldman Sachs advises its customers to buy the stock. The target price is unchanged at GBp 180.
ANALYST RECOMMENDATIONS : Apple, Aviva, Biogen, Comerica Incorporated, Tesla...
Deutsche Bank lifted Hershey's price target ahead of second quarter results. RBC is short on Unimlever and has lowered its target after the group warned that high raw material prices were hitting margins and that it could be forced to raise prices to protect profits. After posting strong results, Vodafone gets a Buy from Goldman Sachs. Arvinas gets higher PT from Wedbush due to its collaboration with Pfizer.